Market Overview - The U.S. stock market remains strong despite concerns over credit downgrade and fiscal outlook, with major indexes finishing higher due to optimism from U.S.-China trade talks [1] - A temporary 90-day pause in tariffs and an agreement to lower mutual tariffs to 10% have positively influenced market sentiment [1] - The S&P 500 has closed higher in 16 of the past 19 trading days, indicating a strong performance [1] Inflation and Economic Indicators - Easing inflation indicators, with both CPI and PPI showing signs of cooling, have contributed to market buoyancy [2] - Despite Moody's downgrade raising long-term concerns about debt, the focus remains on near-term growth momentum and improving global trade relations [2] Investment Strategy - A relative price strength strategy is recommended, focusing on stocks that outperform the broader market [2][4] - Stocks that are underperforming on fundamental factors should be avoided, while those outperforming their sectors in price should be selected for better returns [5] Stock Recommendations - Recommended stocks based on relative price strength include Great Lakes Dredge & Dock Corporation (GLDD), Sprouts Farmers Market, Inc. (SFM), EverQuote, Inc. (EVER), and Encompass Health Corp. (EHC) [3] Screening Parameters - Stocks should be screened based on relative price change over 12 weeks, 4 weeks, and 1 week, as well as positive current-quarter estimate revisions [8] - Only Zacks Rank 1 (Strong Buy) stocks that have historically outperformed the S&P 500 are considered [9] Company Highlights - **Great Lakes Dredge & Dock Corporation (GLDD)**: Market cap of $760.8 million, with a 34.8% upward revision in 2025 earnings estimates and a 15.6% increase in shares over the past year [11][10] - **Sprouts Farmers Market, Inc. (SFM)**: Unique grocery model with a market cap of $1.5 billion, showing a 35.5% growth in 2025 earnings estimates and a 115.4% increase in shares over the past year [12][13] - **EverQuote, Inc. (EVER)**: Market cap of $867 million, with a 33% growth in 2025 earnings estimates, but shares have decreased by 3.5% in the past year [13][14] - **Encompass Health Corp. (EHC)**: Market cap not specified, with a 13.1% growth in 2025 earnings estimates and a 41.2% increase in shares over the past year [15]

Group 1: Great Lakes Dredge & Dock Corporation (GLDD) - Great Lakes Dredge & Dock Corporation is a dredging services company with a Zacks Rank 1 (Strong Buy) [1] - The Zacks Consensus Estimate for its current year earnings has increased by 34.8% over the last 60 days [1] - The company has a PEG ratio of 1.01, which is lower than the industry average of 1.59, and possesses a Growth Score of A [1] Group 2: Encompass Health Corporation (EHC) - Encompass Health Corporation is a post-acute healthcare services company with a Zacks Rank 1 [2] - The Zacks Consensus Estimate for its current year earnings has increased by 4.4% over the last 60 days [2] - The company has a PEG ratio of 2.46, which is lower than the industry average of 2.73, and possesses a Growth Score of A [2] Group 3: Unisys Corporation (UIS) - Unisys Corporation is an information technology solutions company with a Zacks Rank 1 [3] - The Zacks Consensus Estimate for its current year earnings has increased by 132% over the last 60 days [3] - The company has a PEG ratio of 0.62, significantly lower than the industry average of 2.62, and possesses a Growth Score of B [3]

Encompass Health (EHC) 2025 Conference Summary Company Overview - Encompass Health is the largest operator of inpatient rehabilitation facilities in the United States [1] Key Points and Arguments Volume Growth and Capacity - Encompass Health has a long-term target for discharge growth of 6% to 8% annually, with total discharge growth exceeding 6% for the last eleven quarters [6][8] - The company reported a first-quarter discharge growth of 10% in the previous year, influenced by an extra day due to leap year and the quarter ending on Easter Sunday [7] - In 2025, Encompass Health plans to open seven new hospitals, with five openings occurring after September, which will affect growth rates [8] - The expected breakdown for discharge growth is approximately two-thirds from same-store growth and one-third from new store growth [8] Occupancy Rates and Bed Expansion - The occupancy rate reached 78.8%, the highest ever recorded, reflecting a systematic increase in private room availability [10] - The percentage of private rooms in the portfolio increased from 40% in 2020 to 56% by the end of Q1 2025, enhancing occupancy levels [12] - Bed expansions are projected to yield high returns, with internal rates of return (IRR) exceeding 30% [13][14] - The company plans to add approximately 120 beds to existing hospitals in 2026 and 2027 [14] Joint Ventures and Market Strategy - Joint ventures (JVs) account for about 40% of Encompass Health's business, with a robust pipeline of potential partnerships [26] - JVs provide advantages such as faster ramp-up times and management fees, enhancing financial returns [27][28] - The company employs a data-driven approach to identify markets for new facilities, considering demographics, competition, and local healthcare needs [19] Medicare Advantage and Payer Mix - The Medicare Advantage payer mix has increased from under 9% in 2018 to approximately 30% in Q1 2025, with ongoing efforts to improve this further [35] - The reimbursement gap between Medicare Advantage and fee-for-service has narrowed from over 25% to less than 2% [36] - The conversion rate for Medicare Advantage referrals to admissions is currently about half that of fee-for-service, indicating significant growth potential [42] Regulatory Environment and Risks - Encompass Health does not foresee immediate risks from potential Medicare cuts, as IRFs represent less than 2% of overall Medicare expenditures [50] - The company is subject to frequent audits and maintains a low bad debt expense of around 2% [51] - There has been no recent discussion regarding the home health transfer policy, which had previously raised concerns [54] Cost Management and Financial Strategy - Construction costs for new facilities are approximately $1.2 million per bed, with bed expansions costing between $800,000 and $850,000 per bed [58] - The company has not observed upward pressure on construction or supply costs, benefiting from reduced demand among contractors [60] - Encompass Health repurchased $32 million of its stock in Q1 2025, indicating a commitment to returning value to shareholders while expanding capacity [64] Additional Important Insights - The aging demographic is a significant driver of growth, with projections indicating that one in five Americans will be over 65 by 2030 [17][18] - The company emphasizes its value proposition in treating complex medical conditions, which resonates with Medicare Advantage plans [40] - Encompass Health's strategic focus on expanding its capacity and improving payer mix positions it well for future growth opportunities [63]

Core Viewpoint - Encompass Health Corporation (EHC) is expanding its operations by planning to build a new 50-bed inpatient rehabilitation hospital in Apollo Beach, Florida, to enhance access to advanced rehabilitation services for patients recovering from serious medical conditions [1][2]. Company Expansion Plans - The new facility in Apollo Beach is part of EHC's broader growth strategy in high-demand markets, aiming to bring personalized rehabilitative care closer to patients and strengthen the brand's visibility in a growing community [2]. - EHC currently operates 167 hospitals across 38 states and Puerto Rico, with plans to open seven de novo hospitals and add 340 beds in 2025, along with a 50-bed satellite hospital [4]. - The company aims to inaugurate six to ten de novo hospitals each year from 2023 to 2027, with annual bed additions ranging from 80 to 120 [5]. Market Position and Performance - EHC's expansion reflects confidence in the profitability of entering underserved, high-growth regions, positioning the company to capture a larger share of the post-acute care market in Florida [3]. - Shares of Encompass Health have increased by 26.6% year-to-date, outperforming the industry growth of 4.2% [6]. - The company holds a Zacks Rank 1 (Strong Buy), indicating strong market confidence [7].

Core Viewpoint - Encompass Health (EHC) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For the fiscal year ending December 2025, Encompass Health is expected to earn $4.98 per share, reflecting a 12.4% increase from the previous year, with a 5.5% rise in the Zacks Consensus Estimate over the past three months [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, indicating superior earnings estimate revisions, which positions Encompass Health favorably for potential market-beating returns [9][10].

Company Overview - Encompass Health (EHC) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook for investors [3] Price Performance - EHC shares have increased by 2.88% over the past week, outperforming the Zacks Medical - Outpatient and Home Healthcare industry, which rose by 2.41% [5] - Over the past month, EHC's price change is 19.07%, significantly higher than the industry's 2.41% [5] - In the last quarter, EHC shares have risen by 16.8%, and over the past year, they have gained 40.17%, while the S&P 500 has moved -5.55% and 13.72%, respectively [6] Trading Volume - EHC's average 20-day trading volume is 1,151,747 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, 7 earnings estimates for EHC have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $4.80 to $4.96 [9] - For the next fiscal year, 7 estimates have also moved upwards without any downward revisions [9] Conclusion - Given the strong price performance, positive earnings outlook, and high momentum score, EHC is positioned as a solid investment opportunity [11]

The Company will award research-funding grants totaling up to $60,000BIRMINGHAM, Ala., May 2, 2025 /PRNewswire/ -- Encompass Health is pleased to announce the opening of its request for 2025 research grant applications due Sept. 30, 2025, at 5 p.m. EST. The grants, totaling up to $60,000, will be awarded for the investigation of the impact or effectiveness of therapies in the inpatient rehabilitation facility post-acute care setting, knowledge translation or implementation science. Grant recipients do not h ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 ______________________________ Encompass Health Corporation (Exact name of Registrant as specified in its Charter) (State or Other Jurisdi ...

Financial Data and Key Metrics Changes - The preliminary voting results indicate that stockholders overwhelmingly approved all proposals, including the election of 10 directors and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm [12]. Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed during the meeting [11][14]. Market Data and Key Metrics Changes - There were no specific market data or key metrics changes mentioned in the meeting [11][14]. Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and the approval of compensation plans, indicating a stable governance structure and commitment to performance incentives [9][10]. Management's Comments on Operating Environment and Future Outlook - Management expressed gratitude towards employees for their dedication and hard work, emphasizing the company's commitment to being a leading healthcare provider [15][16]. Other Important Information - The meeting had no questions submitted from stockholders, indicating a lack of immediate concerns or inquiries regarding the company's operations or future plans [11][14]. Q&A Session All Questions and Answers Question: Were there any questions regarding the proposals? - No questions regarding the proposals were submitted through the annual meeting website [11]. Question: Were there any general questions about the business of the company? - No general questions were submitted through the annual meeting website [14].

Company Overview - Encompass Health Corp. is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a national footprint of 167 hospitals across 38 states and Puerto Rico [2] - The company provides high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery [2] - Encompass Health has received recognition as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare, and Forbes' Most Trusted Companies in America [2] Upcoming Events - Encompass Health will participate in the BofA Securities 2025 Healthcare Conference from May 13-15, 2025 [1] - Doug Coltharp, Executive Vice President and Chief Financial Officer, will engage in a fireside chat on May 13, 2025, from 8:40-9:10 a.m. PT [1] - The presentation will be available via live webcast at investor.encompasshealth.com [1]